Remove 2025 Remove Pharmaceutical Manufacturing Remove Vaccines
article thumbnail

Guaranteeing resilience in vaccine manufacturing

European Pharmaceutical Review

There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.

article thumbnail

Korea’s Minister of Food & Drug Safety: Addressing Medicines Supply Chain Resilience in the Asia-Pacific and Beyond

Quality Matters

We prioritize check-ins with stakeholders such as the Association of Medical Doctors and the Association of Pharmaceutical Manufacturers and Distributors regarding any issues with production. Looking ahead, APEC 2025 will be hosted in Korea. What are your team’s plans for that event?

article thumbnail

Procuring HIV/AIDS medicines from African producers

Quality Matters

Given this dependence on foreign manufacturers, the African Union made regional production a central pillar of its New Public Health Order, and partnerships that support African-produced medicines, vaccines, and other medical products, are central to their efforts. But PEPFAR is looking to change how it does business.